Skip to main content
James G. Peyer

James G. Peyer

Apr 28, 2026

1:43
Before getting into all the details of the drugs you're developing now, could you maybe take us, like, all the way back to, like, when you first entered the field? Like, what were the state of things?
1:55
Oof.
1:55
So when I started getting into the biology of aging as a realistic sort of set of processes that could be modified, this was in the early two thousands, right, two thousand two, two thousand three, which it's crazy to think now that's more than twenty years ago.
2:15
And, and at the time, um, really the intellectual leaders in the field were, number one, um, Aubrey De Grey, who had just come out with this idea of the seven deadly things, right? That there were these different processes that broke down during aging that could be repaired, and if you repaired all of those things, we wouldn't age anymore, which was this real quantum leap in thinking of, of h- of about, of aging as a, a set of discrete processes.
2:49
And then the, um, and the other leader that I thought really, really was important but hasn't, um, been as big a part of the community since is Michael Fossel.
3:03
So Fossel is a professor at, uh, at Michigan State in Lansing, and had come out with a book in nineteen ninety-six called Reversing Human Aging.
3:13
I think it's nineteen ninety-six.

1 HR 1 MIN LATER

64:36
Like, what is your take on sort of the like why the culture got so excited about longevity and, you know, what effect does that have on this field?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.